SCHEMBL1132279

SCHEMBL1132279

[c]1ncccc1-c1c[nH]nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909130 0.72
SCHEMBL42036 0.72
SCHEMBL291290 0.72
SCHEMBL1925074 0.71 GOT1 (0.33)
SCHEMBL6277353 0.68
SCHEMBL252798 0.68
SCHEMBL6492459 0.68
SCHEMBL87533 0.67
SCHEMBL13931019 0.67 KDM4E (0.35)
SCHEMBL155358 0.67 KDM4E (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023133271-A1 BICYCLIC PHTHALAZIN-1(2H)-ONE DERIVATIVES AND RELATED USES NodThera Limited (GB) 2023-07-13 WO claimed
US-20130231333-A1 ESTROGEN RECEPTOR MODULATORS AND USES THEREOF ARAGON PHARMACEUTICALS, INC. (US) 2013-09-05 US claimed
US-20110189192-A1 NOVEL COMPOUNDS THAT ARE ERK INHIBITORS MERCK SHARP & DOHME LLC 2011-08-04 US claimed
CN-102015693-A Compounds as ERK inhibitors SCHERING CORP 2011-04-13 CN claimed
EP-2260031-A1 COMPOUNDS THAT ARE ERK INHIBITORS Schering Corporation (US) 2010-12-15 EP claimed
WO-2009105500-A1 COMPOUNDS THAT ARE ERK INHIBITORS SCHERING CORPORATION (US) 2009-08-27 WO claimed
US-20090111801-A1 SUBSTITUTED PYRAZINONE DERIVATIVES FOR USE AS A MEDICINE JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-30 US claimed
US-20070219197-A1 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives ASTELLAS PHARMA GMBH (DE) 2007-09-20 US claimed
EP-0523585-B1 Improvements in or relating to beta lactam production SANDOZ AG (CH) 2005-02-02 EP claimed
WO-2023133271-A1 BICYCLIC PHTHALAZIN-1(2H)-ONE DERIVATIVES AND RELATED USES NodThera Limited (GB) 2023-07-13 WO disclosed
US-20230144106-A1 COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY SYROS PHARMACEUTICALS INC (US) 2023-05-11 US disclosed
EP-3774741-B1 ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES UCB Biopharma SRL (BE) 2022-06-08 EP disclosed
CN-108699035-B Novel compounds 特殊治疗有限公司 2021-10-15 CN disclosed
US-20210188833-A1 COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY SYROS PHARMACEUTICALS INC (US) 2021-06-24 US disclosed
WO-1988000468-A1 PYRIDONE-PYRIDYL-IMIDAZOLYL AND TRIAZOLYL COMPOUNDS AND THEIR USE AS CARDIOTONIC AGENTS RORER INTERNATIONAL (OVERSEAS) INC. (US) 1988-01-28 WO disclosed
WO-1985004659-A1 INTERMEDIARY PRODUCTS OF CEPHALOSPORINE, PREPARATION PROCESS THEREOF AND UTILIZATION THEREOF BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 1985-10-24 WO disclosed
WO-1985004404-A1 CEPHALOSPORINS BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 1985-10-10 WO disclosed
EP-0156771-A2 Cephalosporins BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 1985-10-02 EP disclosed
EP-0037380-B1 NEW PROCESS FOR THE PRODUCTION OF CEPHALOSPORIN ANTIBIOTICS, AND NOVEL INTERMEDIATES USED IN SUCH PROCESS AND THEIR PRODUCTION BIOCHEMIE Gesellschaft m.b.H. (AT) 1984-09-12 EP disclosed
EP-0037380-A2 New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production BIOCHEMIE Gesellschaft m.b.H. (AT) 1981-10-07 EP disclosed